During the past decade, Upper Valley Medical Center conducted 134 clinical trials. In the 10-year time frame, 134 clinical trials started and 203 clinical trials were completed, i.e. on average, 151.5% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 77 clinical trials were completed. i.e. 135.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Upper Valley Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 142 trials, followed by "Alliance for Clinical Trials in Oncology" with 94 trials sponsored, "SWOG Cancer Research Network" with 86 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 25 trials sponsored and "Radiation Therapy Oncology Group" with 25 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Upper Valley Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 248 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator and "SWOG Cancer Research Network" with 12 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Upper Valley Medical Center" are "Breast Cancer" (40 trials), "Lung Cancer" (22 trials), "Lymphoma" (21 trials), "Recurrent Breast Carcinoma" (14 trials) and "Colorectal Cancer" (13 trials). Many other conditions were trialed in "Upper Valley Medical Center" in a lesser frequency.

Most popular intervention types in "Upper Valley Medical Center" are "Drug" (333 trials), "Other" (191 trials), "Biological" (154 trials), "Procedure" (81 trials) and "Radiation" (62 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (89 trials), "Quality-of-Life Assessment" (56 trials), "Carboplatin" (36 trials), "Paclitaxel" (35 trials) and "placebo" (31 trials). Other intervention names were less common.

The vast majority of trials in "Upper Valley Medical Center" are 321 trials for "All" genders, 62 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Upper Valley Medical Center". undefined are not yet recruiting, 56 are recruiting, 112 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 186 completed trials in Upper Valley Medical Center, 3 suspended trials, and 31 terminated clinical trials to date.

Out of the total trials that were conducted in Upper Valley Medical Center, 10 "Phase 1" clinical trials were conducted, 205 "Phase 2" clinical trials and 177 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".